What You Should Know:
- Endeavor Health, a Chicagoland-based integrated health system announced the development of a groundbreaking, fully cloud-based digital pathology platform in collaboration with Google Cloud, establishing a novel model poised to reshape the future of this critical medical field.
- Endeavor Health's pioneering model represents a significant leap forward from previous industry efforts to explore digital pathology. By establishing the first fully connected,
Read More
Digital Pathology
Proscia Secures $50M to Accelerate AI-Driven Digital Pathology
What You Should Know:
- Proscia, a software company focused on digitizing and applying AI to pathology, has announced a $50M funding round, bringing its total capital raised to $130M.
- The funding, led by Insight Partners, AI Capital Partners, and Triangle Peak Partners, will be used to further expand the adoption of Proscia's platform, integrate more AI capabilities, and leverage strategic OEM partnerships with industry giants like Agilent Technologies and Siemens
Read More
elea Raises $4.3M AI-Powered Pathology Operating System
What You Should Know:
- elea, an innovative AI platform designed to supercharge healthcare professionals' ability to deliver life-saving diagnoses and care, has announced a $4.3M (€4M)funding round led by Fly Ventures and Giant Ventures.
- The company has also secured a milestone partnership with one of Germany's largest and most critical Medizinische Versorgungszentrum (MVZ) hospital groups.
Addressing the Healthcare Crisis with AI
elea was founded to address the growing
Read More
Stemline Therapeutics to Deploy Tempus Next’s AI-Enabled Care Pathway Intelligence Platform
What You Should Know:
- Tempus, a provider of AI-driven precision medicine, and Stemline Therapeutics, Inc. ("Stemline"), a wholly-owned subsidiary of the Menarini Group announced a new collaboration to improve the use of ESR1 testing in metastatic breast cancer (mBC).
- The partnership will leverage Tempus' Next platform, an AI-enabled care pathway intelligence tool, to help clinicians determine when ESR1 testing may be appropriate for their patients.
Challenges in ESR1
Read More
PathAI Launches PathAssist Derm, an AI-Powered Tool for Skin Lesion Analysis
What You Should Know:
- PathAI, a provider of AI-powered pathology solutions, today announced the launch of PathAssist Derm, an innovative tool designed to streamline the analysis of skin lesions.
- Available now on the AISight® Image Management System (IMS), this research tool automates specimen orientation and identification, enabling pathologists to review samples more efficiently and accurately.
PathAssist Derm Capabilities
PathAssist Derm is the latest addition to
Read More
Mayo Clinic Launches Digital Pathology Platform
What You Should Know:
- Mayo Clinic launches Mayo Clinic Digital Pathology, a platform designed to leverage the power of its vast digital slide archive to transform pathology and accelerate medical advancements.
- The initiative, powered by a collaboration with NVIDIA and Aignostics, aims to unlock the potential of digital pathology and drive innovation in diagnostics and treatment.
Addressing the Challenges of Analog Pathology
Traditional pathology practices often rely on
Read More
Deciphex Secures $32.3M for AI-Powered Digital Pathology
What You Should Know:
- Deciphex, a leader in AI-powered digital pathology, has closed its Series C financing, raising $32.3 million to address the acute global pathology crisis. Led by Molten Ventures with significant participation from ACT Venture Capital, Seroba, Charles River Laboratories (NYSE: CRL), IRRUS Investments, HBAN Medtech Syndicate and Nextsteps Capital, the funding will advance Deciphex's mission to democratize access to high-quality
Read More
The Role of AI-Enabled Pathology in Enhancing Patient Care
There’s no doubt that cancer screening, early detection, and swift intervention are invaluable for improving patients’ health outcomes. In this process, once a clinician has determined a need for a tissue biopsy after detecting an abnormality, diagnostic accuracy and efficiency become crucial factors in the treatment journey.
We’ve seen great advancements when it comes to screening and targeted therapies. However, these treatments cannot occur without an accurate and timely diagnosis.
Read More
Owkin, Proscia Partner to Streamline MSI Testing for Colorectal Cancer
What You Should Know:
- Owkin, an AI-biotech company specializing in precision medicine, and Proscia, a leader in AI-enabled pathology solutions, have announced a strategic partnership to improve MSI testing for colorectal cancer (CRC). This collaboration aims to enhance the efficiency and accessibility of MSI screening, ultimately leading to better patient outcomes.
- Beyond MSI testing, Owkin and Proscia plan to collaborate on developing and commercializing additional AI solutions
Read More
Q/A: Proscia Co-Founder Talks Impact of DICOM in Digital Pathology
The world of digital pathology is undergoing a significant transformation, with the adoption of DICOM (Digital Imaging and Communications in Medicine) emerging as a game-changer. This international standard, already widely used in radiology, is poised to transform how pathology images and data are stored, shared, and analyzed.
By promoting interoperability among various hardware and software solutions, DICOM empowers laboratories to build more efficient and scalable digital pathology
Read More
